isotyp
antibodi
respons
bovin
ind
p
simian
sall
p
rotaviru
sall
rotaviru
protein
serum
colostrum
milk
analys
elba
three
group
vaccin
cow
nonvaccin
control
pregnant
cow
vaccin
intramuscularli
intramammarili
recombin
baculovirusexpress
sall
rotaviru
vlp
triplelay
viruslik
particl
contain
rotaviru
clp
doublelay
corelik
particl
contain
rotaviru
inactiv
sall
rotaviru
respect
rotaviru
antigen
titer
highest
elisa
vlp
vaccin
compar
inactiv
sall
vaccin
iggl
igm
geometr
mean
antibodi
titer
gmt
rotaviru
titer
bovin
rotaviru
vs
sall
rotaviru
er
signtjicantli
isotyp
group
gmt
serum
calv
vaccin
group
significantli
p
higher
control
group
colostrum
iggl
iga
rotaviru
antibodi
titer
significantli
elev
vlp
iggl
gmt
iga
gmt
clp
iggl
gmt
iga
gmt
ill
iggl
gmt
iga
gmt
vaccin
cow
compar
control
cow
gmt
iga
gmt
iggl
iga
gmt
rotaviru
sign
cantli
elev
milk
vlp
clp
vaccin
cow
compar
sall
vaccin
control
cow
isotyp
antibodi
respons
serum
colostrum
milk
parallel
respons
rotaviru
titer
iofold
lower
cow
vaccin
vlp
significantli
enhanc
serum
colostr
milk
antibodi
titer
rotaviru
result
demonstr
rotaviru
antibodi
titer
serum
colostrum
milk
significantli
enhanc
use
noninfecti
vlp
clp
inactiv
sall
rotaviru
vaccin
vlp
clp
vaccin
induc
highest
antibodi
respons
correspond
higher
rotaviru
antigen
titer
measur
elisa
copyright
elsevi
scienc
ltd
studi
use
gnotobiot
calv
howev
efficaci
question
evalu
field
condit
presum
due
widespread
presenc
matern
antibodi
neutral
vaccin
second
approach
vaccin
develop
involv
matern
vaccin
enhanc
lactogen
immunit
tr
transfer
passiv
protect
investig
shown
vaccin
cow
live
inactiv
brv
vaccin
significantli
increas
colostr
antibodi
titer
brv
passiv
protect
calv
diarrhoea
follow
exp
ily
brv
challeng
studi
howev
brv
vaccin
efficaci
variabl
field
recent
use
baculoviru
express
system
recombin
viral
multiprotein
structur
produc
refer
viruslik
particl
vlp
corelik
particl
clp
r
articl
report
initi
p
roy
cowork
bluetongueviru
labb
cowork
rotaviru
repres
new
gener
noninfecti
stabl
antigen
authent
highli
immunogen
vaccin
crawford
et
al
describ
product
triplelay
rotaviruslik
particl
vlp
coexpress
brv
sall
inner
respect
simian
sall
rotaviru
outer
capsid
protein
gene
insect
cell
use
baculoviru
express
system
sal
vlp
previou
studi
vlp
includ
one
produc
bluetongu
viru
indic
vlp
antigen
authent
immun
respons
induc
vlp
mimic
induc
intact
therefor
object
compar
use
inactiv
sall
rotaviru
vaccin
mimic
exist
inactiv
brv
commerci
vaccin
sall
clp
compris
rotaviru
vlp
compris
rotaviru
subunit
vaccin
immun
pregnant
cow
boost
antibodi
brv
colostrum
milk
induct
passiv
immun
newborn
calv
studi
use
vaccin
rout
time
intramuscular
week
preportum
intramammarili
week
preportum
adjuv
incomplet
freundsb
evok
maxim
antibodi
respons
previous
use
elisa
investig
isotypespecif
antibodi
titer
rotaviru
rotaviru
protein
serum
colostrum
milk
nonvaccin
cow
cow
vaccin
inactiv
sall
sall
clp
vlp
subunit
vaccin
sall
strain
simian
rotaviru
p
ind
strain
brv
cultiv
fetal
rhesu
monkey
kidney
cell
presenc
trypsin
previous
use
elisa
sall
ind
brv
vaccin
sall
rotavirusinfect
cell
subject
two
cycl
freez
thaw
suspens
centrifug
remov
cellular
debri
soog
min
supernat
lysat
store
rotaviru
titer
sall
ind
supernat
lysat
approxim
ffuml
elisa
rotaviru
supernat
fluid
semipurifi
centrifug
vaccin
volum
number
sucros
cushion
h
viral
pellet
resuspend
x
origin
volum
tri
buffer
ph
contain
cacl
triscacl
aliquot
store
control
antigen
prepar
mockinfect
cell
treat
store
ident
manner
recombin
triplelay
vlp
doublelay
clp
gener
coexpress
baculoviru
brv
sal
rotaviru
brv
sall
rotaviru
respect
purifi
cscl
gradient
previous
western
blot
use
confirm
presenc
respect
rotaviru
protein
vlp
clp
vaccin
size
morpholog
clp
vlp
examin
use
electron
microscopi
ammonium
molybd
ph
use
neg
stain
sall
rotaviru
vaccin
supernat
infect
cell
cultur
lysat
inactiv
bei
h
mechan
residu
inactiv
sodium
thiosulf
final
concentr
rotaviru
inactiv
verifi
loss
infect
cell
vaccin
store
seventeen
pregnant
holstein
cow
ohio
agricultur
research
develop
center
dairi
research
herd
randomli
assign
four
experiment
group
cow
complet
least
one
lactat
previous
vaccin
rotaviru
seroposit
rotaviru
antibodi
due
natur
field
exposur
inocul
vlp
vaccin
cow
receiv
ug
vlp
pg
vlp
clp
vaccin
cow
receiv
pug
clp
sal
vaccin
cow
receiv
beiinactiv
sall
rotaviru
titer
x
pfuml
prior
inactiv
remain
four
cow
uninocul
control
vaccin
cow
inocul
intramuscular
im
inject
gluteal
region
ml
hip
one
week
dri
approxim
week
prior
anticip
calv
date
ml
vlp
clp
inactiv
sall
rotaviru
emulsifi
immedi
prior
vaccin
equal
volum
incomplet
freund
adjuv
ifa
two
week
first
im
inject
cow
vaccin
intramammarili
imm
similar
volum
vlp
clp
inactiv
sall
ifa
inoculum
infus
mammari
quarter
mlquarter
use
steril
teat
infus
canula
infus
teat
end
clean
scrub
cotton
pad
soak
alcohol
blood
sampl
collect
group
week
dri
time
initi
inject
calv
postpartum
day
ppd
ppd
serum
extract
mammari
secret
sampl
colostrum
milk
obtain
ppd
entir
first
milk
colostrum
obtain
cow
calv
milk
sampl
collect
cow
manual
express
equal
volum
quarter
colostrum
milk
sampl
centrifug
min
supernat
remov
heat
inactiv
min
centrifug
min
obtain
clear
whey
filter
nm
sampl
store
frozen
aliquot
lsofypespecif
antibodi
respons
rofaviru
viru
protein
cow
em
fernandez
et
al
modif
indirect
elisa
describ
use
assess
rel
concentr
rotaviru
antigen
vaccin
prepar
separ
plate
coat
mab
ascit
broadli
reactiv
subgroup
specif
neg
control
plate
coat
antiserum
goat
doublelay
sal
rotaviru
particl
verifi
react
western
blot
preimmun
hyperimmun
serum
verifi
react
western
blot
semipurifi
brv
produc
gnotobiot
pig
overnight
incub
c
nonfat
dri
milk
phosphatebuff
salin
solut
ph
contain
tween
pbst
appli
block
reagent
h
vaccin
sampl
dilut
ad
duplic
well
incub
h
guinea
pig
hyperimmun
antiserum
group
brv
ncdvcodi
strain
ad
secondari
antibodi
dilut
follow
sheep
antiguinea
pig
igg
conjug
horseradish
peroxidaset
dilut
substrat
sulfon
acid
abt
final
concentr
hydrogen
peroxid
ad
plate
read
cutoff
valu
calcul
previous
antigen
end
point
titer
express
reciproc
highest
sampl
dilut
absorb
nm
sd
absorb
control
well
indirect
isotyp
antibodi
elisa
use
quantit
isotyp
antibodi
titer
ind
brv
sal
rotaviru
sall
rotaviru
serum
colostrum
milk
optim
volum
reagent
dilut
determin
checkerboard
titrat
use
rotaviru
antibodi
posit
neg
standard
plate
wash
use
pbst
prior
addit
standard
volum
mlwell
reagent
dilut
pbst
follow
h
incub
reagent
humid
co
atmospher
elisa
test
modifi
detect
antibodi
rotaviru
describ
rotaviru
antibodi
assay
microtit
nunc
coat
ml
bicarbon
buffer
ph
hyperimmun
serum
brv
produc
gnotobiot
pig
captur
antibodi
plate
store
day
c
wash
twice
ind
brv
sall
rotaviru
mockinfect
cell
cultur
control
fluid
ad
test
reagent
ad
follow
sequenc
serial
dilut
test
sampl
start
ad
antigenco
control
mock
infect
well
secondari
antibodi
consist
mab
ascit
bovin
maxisorp
immunopl
nunc
napetvil
il
fboehr
mannheim
corpor
indianapoli
smaxisorp
immunopl
nunc
napervil
il
secret
mab
bovin
iggl
iga
igm
kindli
provid
dr
srikumaran
univ
ne
lincoln
ne
dr
goldsbi
amherst
univ
amherst
iggl
igm
dilut
iga
dilut
ad
separ
plate
indic
antibodi
goat
antimous
igg
h
l
f
ab
conjug
alkalin
phosphatasefi
dilut
loooo
substrat
pnitrophenyl
phosphat
diethanolamin
buffer
dea
ph
antiboaiy
assay
nunc
plate
coat
antiserum
goat
doubl
layer
sa
rotaviru
particl
mab
captur
respect
block
pbstfetal
bovin
serum
h
supemat
fluid
lysat
insect
cell
infect
recombin
baculovirus
express
sal
rotaviru
dilut
looo
dilut
lo
infect
wildtyp
wt
baculoviru
dilut
respect
ad
serial
dilut
serum
colostrum
milk
sampl
ad
plate
follow
secondari
antibodi
consist
biotinyl
mab
bovin
iggl
igm
dilut
indic
antibodi
peroxidaseconjug
streptavidin
dilut
loooo
substrat
abt
detect
iga
antibodi
system
mab
conjug
alkalin
phosphatas
dilut
use
follow
substrat
pnitrophenol
phbsphate
dea
buffer
antibodi
assay
immulon
plate
coat
directli
supemat
fluid
lysat
cell
infect
recombin
baculoviru
express
sal
rotaviru
dilut
lysat
wt
baculovirusinfect
cell
control
dilut
sampl
ad
remaind
assay
conduct
describ
ii
absorb
assay
determin
elisa
reader
nm
alkalin
phosphatas
system
nm
peroxidas
system
elisa
antibodi
titer
express
reciproc
highest
sampl
dilut
absorb
sd
background
control
sampl
mockinfect
fluid
wt
control
well
test
includ
posit
neg
control
serum
geometr
mean
titer
gmt
confid
interv
ci
calcul
vaccin
group
describ
previous
statist
analys
perform
log
transform
reciproc
antibodi
titer
analysi
varianc
perform
least
signific
differ
test
lsd
ci
use
test
signific
differ
p
among
gmt
mab
kindli
provid
ii
hyperimmun
serum
doubl
capsid
rotaviru
particl
dc
rv
produc
goat
reactiv
verifi
western
blot
hyperimmun
serum
semipurifi
group
brv
lincoln
strain
contain
dc
rv
tripl
capsid
rotaviru
tc
rv
produc
gnotobiot
pig
reactiv
verifi
western
blot
dantigen
titer
express
reciproc
final
posit
dilut
mean
follow
letter
significantli
differ
follow
differ
letter
significantli
differ
p
valu
parenthes
repres
confid
interv
cl
vlp
report
data
shown
triplelay
particl
averag
nm
diamet
dark
stain
core
evid
vlp
prepar
doublelay
particl
averag
nm
diamet
observ
clp
vaccin
rotaviru
antigen
titer
rel
titer
rotaviru
antigen
vaccin
prepar
estim
tabl
rel
antigen
titer
vlp
inactiv
sall
untreat
control
x
io
pfuml
sall
rotaviru
reactiv
mab
either
elisa
respect
clp
rotaviru
vaccin
react
mab
rotaviru
elisa
vaccin
antigen
titer
mab
elisa
vlp
clp
sallinactiv
control
vaccin
antigen
titer
reactiv
polyclon
antibodi
either
goat
antidc
pig
antidc
tc
elisa
vlp
clp
sallinactiv
live
differ
seen
titer
untreat
control
versu
inactiv
sall
rotaviru
antibodi
reagent
signific
differ
serum
colostrum
milk
antibodi
titer
sall
versu
ind
rotaviru
strain
elisa
henc
gmt
summar
tabl
tabl
ind
brv
sinc
signific
differ
antibodi
titer
cow
given
vs
pg
vlp
gmt
comput
six
cow
gmt
ci
isotyp
rotaviru
antibodi
serum
vaccin
control
cow
summar
tabl
initi
vaccin
prepartum
day
cow
seroposit
brv
indic
previou
field
exposur
signific
differ
observ
isotypespecif
gmt
among
group
isotyp
rotaviru
antibodi
gmt
postvaccin
serum
calv
ppd
summar
tabl
cow
vaccin
vlp
clp
inactiv
sal
develop
significantli
enhanc
antibodi
gmt
associ
iggl
igm
compar
control
cow
highest
gmt
brv
postvaccin
serum
calv
associ
vlp
clp
sall
vaccin
cow
elev
least
gmt
control
cow
iggl
antibodi
gmt
serum
vaccin
cow
significantli
increas
least
iggl
gmt
control
cow
increas
serolog
iga
gmt
occur
group
vaccin
iggl
iga
gmt
brv
colostrum
significantli
elev
vaccin
cow
compar
control
cow
tabl
moreov
iggl
iga
gmt
significantli
higher
colostrum
vlp
isotypespecif
antibodi
respons
rotaviru
viru
protein
cow
em
fernandez
et
al
mean
follow
letter
significantli
differ
follow
differ
letter
significantli
differ
p
valu
parenthes
repres
confid
interv
cl
clp
cow
two
group
rotaviru
antibodi
isotyp
gmt
milk
ppd
group
summar
tabl
although
lower
gmt
detect
milk
compar
colostrum
vaccin
cow
rel
distribut
brv
antibodi
among
differ
isotyp
similar
gmt
rotaviru
associ
iggl
iga
igm
milk
significantli
higher
vaccin
cow
control
cow
gmt
brv
antibodi
isotyp
except
significantli
higher
vlp
clp
vaccin
cow
sal
vaccin
cow
iggl
predomin
isotyp
follow
iga
gmt
ci
isotyp
antibodi
rotaviru
serum
colostrum
milk
vaccin
control
cow
summar
tabz
signific
differ
antibodi
isotyp
titer
serum
among
four
group
rotaviru
protein
vaccin
prepartum
day
tabl
calv
ppd
significantli
enhanc
antibodi
gmt
serum
associ
igm
vaccin
group
also
iggl
vlp
clp
vaccin
cow
compar
control
group
highest
gmt
serum
detect
vlp
clp
vaccin
cow
gmt
respect
least
lfold
gmt
control
cow
significantli
elev
gmt
rotaviru
protein
serum
calv
associ
iggl
igm
vlp
vaccin
cow
significantli
increas
isotyp
antibodi
titer
detect
associ
igm
associ
sal
vaccin
cow
compar
control
cow
serum
calv
signific
differ
gmt
isotyp
detect
clp
vaccin
cow
control
cow
colostrum
milk
iggl
iga
gmt
significantli
elev
vaccin
group
compar
control
significantli
higher
vlp
clp
sa
vaccin
cow
tabl
significantli
higher
gmt
colostrum
milk
detect
vlp
vaccin
cow
associ
iggl
iga
colostrum
titer
least
higher
control
cow
rotaviru
major
etiolog
agent
bovin
neonat
variou
vaccin
strategi
use
prevent
rotavir
use
live
attenu
oral
rotaviru
vaccin
calv
stimul
activ
immun
shown
variabl
result
field
vaccin
failur
larg
attribut
presenc
matern
antibodi
rotaviru
neutral
vaccin
viru
gut
widespread
presenc
matern
antibodi
degre
attenu
need
insur
safeti
live
vaccin
neonat
limit
feasibl
activ
immun
young
calv
highli
suscept
enter
viral
infect
therefor
transfer
effect
passiv
immun
via
colostrum
milk
play
pivot
role
confer
protect
immedi
birth
sever
studi
highlight
import
immun
pregnant
dam
last
third
gestat
period
confer
effect
passiv
immun
prevent
brv
associ
strategi
associ
feed
colostrum
milk
contain
high
level
specif
antibodi
presenc
antibodi
intestin
lumen
colostrumf
calv
studi
calv
suggest
iggl
antibodi
absorb
colostrum
transud
serum
back
intestin
therebi
complement
role
milk
antibodi
passiv
immun
increas
antibodi
titer
brv
mammari
secret
follow
parenter
vaccin
cow
use
inactiv
brv
vaccin
describ
mebu
et
al
snodgrass
et
al
latter
report
calv
born
vaccin
dam
partial
protect
homotyp
brv
challeng
probabl
explan
lack
protect
high
challeng
dose
viru
milk
antibodi
titer
protect
threshold
destruct
import
epitop
formalin
inactiv
subsequ
studi
uk
vaccin
farm
condit
singl
herd
demonstr
reduc
brv
shed
diarrhoea
investig
describ
variabl
result
experiment
field
brv
vaccin
trial
depend
upon
vaccin
strain
titer
dose
adjuv
inactiv
agent
rout
vaccin
document
need
improv
brv
vaccin
field
saif
et
describ
optim
method
vaccin
pregnant
cow
brv
boost
antibodi
mean
follow
letter
significantli
differ
follow
differ
letter
significantli
differ
p
valu
parenthes
repres
confid
interv
cl
titer
colostrum
milk
use
combin
im
imm
rout
pregnant
cow
vaccin
modifi
live
inactiv
brv
ifa
significantli
increas
colostr
milk
antibodi
titer
mainli
associ
iggl
follow
iga
igm
saif
cowork
also
report
significantli
increas
viru
neutral
iggl
brv
antibodi
titer
colostrum
follow
immun
correl
passiv
protect
newborn
calf
homotyp
brv
challeng
sever
approach
develop
produc
safe
j
w
nonrepl
effect
rotaviru
vaccin
earlier
studi
immun
singl
cow
empti
brv
capsid
purifi
brvinfect
cell
lysat
induc
increas
neutral
elisa
antibodi
titer
sall
rotaviru
serum
substanti
neutral
antibodi
elisa
titer
increas
evid
individu
cow
immun
purifi
peptid
suggest
effici
boost
antibodi
respons
cow
present
context
empti
capsid
similarli
baculovirusexpress
fail
induc
neutral
antibodi
passiv
protect
studi
shown
conjug
peptid
correspond
highli
conserv
region
rotaviru
unrel
carrier
molecul
induc
elisa
antibodi
titer
brv
mice
mixtur
peptid
coupl
gave
optim
passiv
protect
neonat
mice
challeng
variou
rotaviru
strain
wherea
alon
induc
neutral
antibodi
partial
passiv
recent
product
doubl
clp
triplelay
vlp
particl
mimic
authent
virion
lack
nucleic
acid
offer
new
approach
develop
safe
highli
immunogen
vaccin
p
roy
et
report
high
antibodi
respons
protect
bluetongu
viru
sheep
vaccin
oil
adjuv
bluetongu
vlp
deriv
multipl
baculoviru
express
vector
antibodi
respons
sall
rotaviru
vlp
deriv
coexpress
individu
recombin
sall
gene
baculoviru
express
system
evalu
mice
rabbit
anim
immun
twice
im
low
dose
pg
sal
vlp
ifa
develop
neutral
elisa
antibodi
immun
rabbit
total
partial
protect
viru
shed
homotyp
rotaviru
challeng
present
studi
demonstr
elisa
antibodi
titer
serum
colostrum
milk
cow
significantli
enhanc
immun
noninfecti
vlp
clp
inactiv
sall
rotaviru
vaccin
administr
im
imm
rout
calv
antibodi
titer
brv
significantli
elev
serum
vaccin
cow
iggl
predomin
antibodi
isotyp
follow
iggl
investig
also
report
significantli
elev
higher
iggl
antibodi
titer
brv
serum
cow
vaccin
live
attenu
homolog
brv
vaccin
unclear
whether
higher
titer
attribut
use
live
viru
bovin
origin
compar
studi
vlp
gener
use
brv
help
resolv
question
contrast
present
studi
iggl
antibodi
titer
brv
significantli
elev
colostrum
milk
vaccin
cow
predomin
antibodi
isotyp
mammari
secret
cow
follow
iga
agre
previou
observ
laboratori
other
use
experiment
brv
vaccin
iggl
iga
titer
significantli
higher
colostrum
milk
vlpand
clpvaccin
cow
compar
sal
lvaccin
control
cow
lower
iggl
antibodi
titer
brv
serum
calv
compar
time
predomin
colostrum
probabl
reflect
activ
transport
iggl
serum
colostrum
prior
parturit
rumin
although
antibodi
gmt
lower
overal
compar
antibodi
gmt
whole
viru
antibodi
respons
greater
respons
similar
isotyp
distribut
pattern
describ
brv
result
confirm
antibodi
respons
vlp
clp
inactiv
rotaviru
mainli
associ
major
structur
protein
account
total
virion
mass
lower
antibodi
gmt
detect
vlp
sal
vaccin
cow
account
respect
virion
mass
also
cow
receiv
vlp
vaccin
contain
significantli
increas
antibodi
respons
detect
colostrum
milk
two
outer
capsid
protein
probabl
explan
differ
observ
respons
vlp
clp
inactiv
sall
rotaviru
vaccin
may
differ
antigen
concentr
vaccin
prepar
measur
elisa
use
panel
mab
polyclon
antibodi
tabl
antigen
concentr
higher
vlp
vaccin
least
respect
sall
vaccin
although
differ
detect
antigen
concentr
clp
vlp
vaccin
expect
protein
undetect
clp
vaccin
compris
beiinactiv
sal
vaccin
show
loss
reactiv
elisa
inactiv
compar
live
viru
confirm
previou
therefor
inactiv
procedur
per
se
account
lower
antigen
vaccin
elisa
lower
antibodi
respons
elicit
viva
present
work
detect
differ
antibodi
respons
cow
vaccin
versu
pug
vlp
howev
lowest
quantiti
vlp
could
induc
significantli
elev
antibodi
respons
determin
analysi
viru
neutral
vn
antibodi
respons
sal
vaccin
cow
confirm
protein
specif
antibodi
respons
vn
antibodi
titer
significantli
elev
highest
serum
colostrum
milk
vlp
vaccin
cow
reflect
presenc
vlp
vaccin
induc
vn
antibodi
vn
titer
significantli
elev
clpvaccin
cow
compar
control
differ
rotaviru
antibodi
titer
use
vaccin
sall
rotaviru
serotyp
unrel
ind
brv
captur
antigen
elisa
probabl
reflect
predomin
crossreact
antibodi
induc
major
rotaviru
structur
protein
howev
crossreact
nonserotyp
specif
epitop
also
present
outer
capsid
protein
establish
heterolog
strain
rotaviru
enhanc
heterolog
homolog
antibodi
respons
seroposit
possibl
elisa
antibodi
respons
sall
often
similar
magnitud
respons
sall
vlpinocul
cow
may
reflect
greater
tendenc
induc
broadli
crossreact
antibodi
one
might
expect
booster
respons
rotaviru
seroposit
cow
howev
direct
comparison
antibodi
titer
versu
difficult
sinc
differ
elisa
test
system
direct
coat
versu
antibodycaptur
use
develop
reliabl
assay
addit
studi
need
determin
protein
specif
immun
respons
differ
use
heterotyp
vaccin
g
p
type
protein
anoth
import
variabl
regard
matern
vaccin
brv
rout
vaccin
previou
report
indic
vaccin
inactiv
live
brv
via
im
imm
rout
induc
higher
antibodi
respons
compar
parenter
rout
howev
parenter
rout
im
subcutan
practic
field
although
dairi
cattl
imm
immun
analog
dri
cow
antibiot
treatment
futur
studi
analys
immunogen
vlp
clp
vaccin
compar
rout
result
confirm
brv
antibodi
titer
serum
colostrum
milk
significantli
enhanc
use
noninfecti
heterolog
vlp
clp
inactiv
sal
vaccin
rotaviru
seroposit
cow
significantli
higher
antibodi
respons
observ
vlp
clp
vaccin
cow
vlp
vaccin
offer
advantag
convent
exist
modifi
live
inactiv
rotaviru
vaccin
includ
exclus
adventiti
agent
extran
antigen
potenti
associ
live
vaccin
consist
product
outer
capsid
protein
immunogen
form
possibl
alter
destroy
inactiv
vaccin
use
sall
clp
assembl
outer
capsid
protein
exist
new
brv
strain
aris
cattl
popul
therefor
creat
novel
approach
constantli
updat
vaccin
efficaci
boost
lactogen
immun
brv
cattl
studi
current
underway
test
efficaci
colostrum
inactiv
sal
vlp
clpvaccin
cow
passiv
protect
calv
brv
